Usak University
Uşak, Center, 64200, Turkey (Türkiye)
NCT Number: NCT07700004
The aim of this study is to examine the validity and reliability of the Turkish Validity and Reliability of The King's Brief Interstitial Lung Disease Questionnaire (K-BILD) in Individuals with Interstitial Lung Involvement Secondary to Rheumatological Diseases.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Uşak, Center, 64200, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-Having been diagnosed with interstitial lung disease by a rheumatologist,
Exclusion criteria
- Presence of a neurological disease
King's Brief lnterstitial Lung Disease Questionnaire, Arthritis Impact Measurement Scales (AIMS2)-Short Form, Modified Medical Research Council (mMRC) Dyspnea Scale, Visual Analog Scale were evaluated.
Time frame: 10 minutes
It consists of 15 items and has a seven-point Likert scale.
Time frame: 15 minutes
AIMS2-SF is a 26-item shortened form of AIMS2 and covers five components of quality of life.
Time frame: 5 minutes
This scale provides information about perceived levels of shortness of breath, consisting of five stages.
Time frame: 3 minutes
In our study, "respiratory distress" will be assessed using the Visual Analog Scale. 0 will be defined as "I never experience respiratory distress," and 10 as "I do not always experience respiratory distress."
Contact information is provided by the study sponsor or research team.
Pamukkale University
Other
Investigation of the Turkish Validity and Reliability of The King's Brief Interstitial Lung Disease Questionnaire (K-BILD) in Individuals With Interstitial Lung Involvement Secondary to Rheumatological Diseases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07217093
Interstitial Lung Disease Due to Systemic Disease, Interstitial Lung Disease Due to Systemic Disease (Disorder)
Potsdam, New York, United States
View Trial DetailsNCT05593588
Common Variable Immunodeficiency, Immune System Diseases
Rochester, Minnesota, United States
View Trial DetailsNCT06195072
Connective Tissue Diseases, Interstitial Lung Disease Due to Systemic Disease
Birmingham, Alabama, United States
View Trial DetailsNCT07345052
Connective Tissue Diseases, Fibrosis
Gothenburg, Sweden
View Trial Details